Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis

Launched by SELCUK UNIVERSITY · Sep 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how common it is for people with systemic sclerosis (also known as scleroderma) to have weak respiratory muscles, a condition called respiratory muscle sarcopenia. The researchers want to find out how often this happens in patients with systemic sclerosis by assessing various aspects of their physical health, including body composition, hand grip strength, and physical performance through simple tests like walking and standing up from a chair.

To participate in the study, individuals should be between the ages of 18 and 75 and must have a confirmed diagnosis of systemic sclerosis. Participants need to be stable in their condition and able to follow instructions during the assessments. However, those with certain health issues, like severe joint problems or infections, or who are pregnant or breastfeeding, cannot take part. If you join, you can expect to undergo some tests that will help researchers understand the impact of systemic sclerosis on muscle strength and overall physical ability.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being between the ages of 18-75
• • 2013 To be diagnosed with systemic sclerosis according to ACR/EULAR classification criteria
• • Being clinically stable
• • Ability to adapt to tests (visual, cognitive, cooperative)
• Exclusion Criteria:
• • Those with neurological and/or musculoskeletal problems that may affect the work
• • Presence of severe joint contracture or painful ulcers that may affect muscle strength measurement and walking
• • Presence of severe infection or sepsis
• • Being diagnosed with a known additional rheumatologic disease
• • Any stage of cancer
• • Pregnant or breastfeeding